Positron Emission Tomography (PET) Nuclear Medicine Market Report 2026
Download Free Sample Buy Now
Positron Emission Tomography (PET) Nuclear Medicine Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Positron Emission Tomography (PET) Nuclear Medicine Market Report 2026

Global Outlook – By Type (F-18, Rb-82, Other Types), By Procedure (Diagnostic Procedures, Hybrid PET CT Procedures, Positron Emission Tomography Procedures, Therapeutic Procedures, Beta Emitter Procedures, Alpha Emitter Procedures, Targeted Radiopharmaceutical Therapy), By Application (Oncology, Cardiology, Neurology, Other Applications), By End User (Hospitals, Diagnostic Centers, Research Institutes) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Positron Emission Tomography (PET) Nuclear Medicine Market Overview

• Positron Emission Tomography (PET) Nuclear Medicine market size has reached to $13.16 billion in 2025

• Expected to grow to $25.7 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%

• Growth Driver: Impact Of Chronic Disease Prevalence On The PET Nuclear Medicine Market

• Market Trend: Advancements In The PET Nuclear Medicine Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Positron Emission Tomography (PET) Nuclear Medicine Market?

Positron Emission Tomography (PET) nuclear medicine is a medical imaging method that employs radioactive materials to visualize and assess metabolic activities within the body. It uses a small amount of radioactive material called a radiotracer to detect changes at the cellular level, allowing doctors to diagnose diseases early.

The main types of positron emission tomography (PET) nuclear medicines are F-18, RB-82, and others. F-18, or fluorine-18, is a radioactive isotope commonly used in positron emission tomography imaging. It is used for various procedures such as diagnostic procedures, single photon emission computed tomography procedures, positron emission tomography procedures, therapeutic procedures, beta emitter procedures, alpha emitter procedures, and brachytherapy procedures and is applied for oncology, cardiology, neurology, and others. It is used by several end users, including hospitals, diagnostic centers, and research institutes.

Positron Emission Tomography (PET) Nuclear Medicine Market Global Report 2026 Market Report bar graph

What Is The Positron Emission Tomography (PET) Nuclear Medicine Market Size and Share 2026?

The positron emission tomography (pet) nuclear medicine market size has grown rapidly in recent years. It will grow from $13.16 billion in 2025 to $15.06 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing cancer diagnosis rates, expansion of nuclear medicine facilities, widespread use of f-18 radiotracers, growth in cardiology imaging applications, improvements in radiopharmaceutical production.

What Is The Positron Emission Tomography (PET) Nuclear Medicine Market Growth Forecast?

The positron emission tomography (pet) nuclear medicine market size is expected to see rapid growth in the next few years. It will grow to $25.7 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to increasing investments in molecular imaging, rising demand for personalized medicine diagnostics, expansion of neurological imaging applications, advancements in radiotracer development, growing adoption of hybrid imaging systems. Major trends in the forecast period include increasing adoption of advanced radiotracers, growing use of pet imaging in oncology, rising integration of pet with ct and mri systems, expansion of precision diagnostic imaging applications, enhanced focus on early disease detection.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Positron Emission Tomography (PET) Nuclear Medicine Market Segmentation

1) By Type: F-18, Rb-82, Other Types

2) By Procedure: Diagnostic Procedures, Hybrid PET CT Procedures, Positron Emission Tomography Procedures, Therapeutic Procedures, Beta Emitter Procedures, Alpha Emitter Procedures, Targeted Radiopharmaceutical Therapy

3) By Application: Oncology, Cardiology, Neurology, Other Applications

4) By End User: Hospitals, Diagnostic Centers, Research Institutes

Subsegments:

1) By F-18 (Fluorine-18): F-18 FDG (Fluorodeoxyglucose), F-18 NaF (Sodium Fluoride), F-18 Fluorocholine

2) By Rb-82 (Rubidium-82): Rb-82 for Myocardial Perfusion Imaging, Rb-82 for Cardiac PET Stress Testing, Rb-82 for Other Cardiac Applications

3) By Other Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Ga-68 (Gallium-68)

What Is The Driver Of The Positron Emission Tomography (PET) Nuclear Medicine Market?

The increasing prevalence of chronic diseases is expected to propel the growth of the positron emission tomography (PET) nuclear medicine market going forward. A chronic disease is a long-lasting health condition that typically persists for three months or more and may require ongoing medical attention or limit daily activities. The rise in chronic diseases is driven by factors such as an aging population, lack of physical activity, unhealthy eating habits, and environmental risks. PET nuclear medicine assists in managing chronic diseases by offering advanced imaging methods that enable early detection, precise diagnosis, and ongoing monitoring of these illnesses. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of chronic diseases drives the growth of the positron emission tomography (PET) nuclear medicine industry.

Key Players In The Global Positron Emission Tomography (PET) Nuclear Medicine Market

Major companies operating in the positron emission tomography (pet) nuclear medicine market are Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Shimadzu Corporation, Toshiba America Medical Systems Inc., Mediso Medical Imaging Systems Ltd., Lantheus Holdings Inc., Jubilant DraxImage Inc., Advanced Accelerator Applications, Eckert & Ziegler Strahlen- und Medizintechnik AG, Cardinal Health, NorthStar Medical Radioisotopes LLC, Bruker Corporation, Digirad Corporation, Neusoft Medical Systems Co. Ltd., Agfa HealthCare NV, Bayer AG, Positron Corporation

Global Positron Emission Tomography (PET) Nuclear Medicine Market Trends and Insights

Major companies operating in the positron emission tomography (PET) nuclear medicine market are developing technologically advanced products, such as PET slice scanners, to provide high-resolution images of metabolic activity. A PET slice scanner is a medical imaging device that combines positron emission tomography (PET) with advanced computing techniques to create detailed, cross-sectional images of metabolic processes in the body, allowing for detecting and monitoring diseases, particularly cancer. For instance, in July 2024, Positron Corporation, a US-based nuclear medicine company, launched the NeuSight PET-CT 3D 64-slice scanner. The NeuSight PET-CT 3D 64-slice scanner sets a new benchmark in imaging and diagnostic precision, combining advanced technology with patient comfort and operational efficiency. It is designed to transform cardiac PET imaging and offers exceptional value and performance at an unmatched price point, making it ideal for cardiology and oncology clinical studies. With superior data acquisition and innovative identification technology, the NeuSight PET-CT enhances scanning speed and accuracy, delivering comprehensive anatomic and functional imaging for heart, tumor, and brain studies across multiple molecular imaging applications.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Positron Emission Tomography (PET) Nuclear Medicine Market?

In February 2023, Lantheus Holdings Inc., a US-based radiopharmaceutical company, acquired Cerveau Technologies Inc. for an undisclosed amount. This acquisition aligns with Lantheus's growth strategy by diversifying its radiopharmaceutical diagnostic imaging agent pipeline to include the most widely used Tau PET imaging agent for Alzheimer's disease. Additionally, it enhances its portfolio with an extensive array of academic collaborations and pharmaceutical partnerships. Cerveau Technologies Inc. is a US-based provider of F 18-labeled positron emission tomography imaging agent that targets Tau tangles in Alzheimer's disease.

Regional Outlook

North America was the largest region in the positron emission tomography (PET) nuclear medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Positron Emission Tomography (PET) Nuclear Medicine Market?

The positron emission tomography (PET) nuclear medicine market consists of sales of radiotracers, dose calibrators, injection systems, patient monitoring systems and simulation tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Positron Emission Tomography (PET) Nuclear Medicine Market Report 2026?

The positron emission tomography (pet) nuclear medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (pet) nuclear medicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Positron Emission Tomography (PET) Nuclear Medicine Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $15.06 billion
Revenue Forecast In 2035 $25.7 billion
Growth Rate CAGR of 14.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Procedure, Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Shimadzu Corporation, Toshiba America Medical Systems Inc., Mediso Medical Imaging Systems Ltd., Lantheus Holdings Inc., Jubilant DraxImage Inc., Advanced Accelerator Applications, Eckert & Ziegler Strahlen- und Medizintechnik AG, Cardinal Health, NorthStar Medical Radioisotopes LLC, Bruker Corporation, Digirad Corporation, Neusoft Medical Systems Co. Ltd., Agfa HealthCare NV, Bayer AG, Positron Corporation
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Positron Emission Tomography (PET) Nuclear Medicine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Positron Emission Tomography (PET) Nuclear Medicine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Positron Emission Tomography (PET) Nuclear Medicine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Positron Emission Tomography (PET) Nuclear Medicine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Advanced Radiotracers

4.2.2 Growing Use Of Pet Imaging In Oncology

4.2.3 Rising Integration Of Pet With Ct And Mri Systems

4.2.4 Expansion Of Precision Diagnostic Imaging Applications

4.2.5 Enhanced Focus On Early Disease Detection

5. Positron Emission Tomography (PET) Nuclear Medicine Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Centers

5.3 Research Institutes

5.4 Oncology Centers

5.5 Cardiology Clinics

6. Positron Emission Tomography (PET) Nuclear Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Positron Emission Tomography (PET) Nuclear Medicine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Positron Emission Tomography (PET) Nuclear Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Positron Emission Tomography (PET) Nuclear Medicine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Positron Emission Tomography (PET) Nuclear Medicine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Positron Emission Tomography (PET) Nuclear Medicine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Positron Emission Tomography (PET) Nuclear Medicine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Positron Emission Tomography (PET) Nuclear Medicine Market Segmentation

9.1. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

F-18, Rb-82, Other Types

9.2. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostic Procedures, Hybrid PET CT Procedures, Positron Emission Tomography Procedures, Therapeutic Procedures, Beta Emitter Procedures, Alpha Emitter Procedures, Targeted Radiopharmaceutical Therapy

9.3. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Cardiology, Neurology, Other Applications

9.4. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Diagnostic Centers, Research Institutes

9.5. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of F-18, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

F-18 FDG (Fluorodeoxyglucose), F-18 NaF (Sodium Fluoride), F-18 Fluorocholine

9.6. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of Rb-82, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rb-82 for Myocardial Perfusion Imaging, Rb-82 for Cardiac PET Stress Testing, Rb-82 for Other Cardiac Applications

9.7. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Ga-68 (Gallium-68)

10. Positron Emission Tomography (PET) Nuclear Medicine Market Regional And Country Analysis

10.1. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market

11.1. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Positron Emission Tomography (PET) Nuclear Medicine Market

12.1. China Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Positron Emission Tomography (PET) Nuclear Medicine Market

13.1. India Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Positron Emission Tomography (PET) Nuclear Medicine Market

14.1. Japan Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Positron Emission Tomography (PET) Nuclear Medicine Market

15.1. Australia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market

16.1. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market

17.1. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Positron Emission Tomography (PET) Nuclear Medicine Market

18.1. Taiwan Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Positron Emission Tomography (PET) Nuclear Medicine Market

19.1. South East Asia Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market

20.1. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Positron Emission Tomography (PET) Nuclear Medicine Market

21.1. UK Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Positron Emission Tomography (PET) Nuclear Medicine Market

22.1. Germany Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Positron Emission Tomography (PET) Nuclear Medicine Market

23.1. France Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Positron Emission Tomography (PET) Nuclear Medicine Market

24.1. Italy Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Positron Emission Tomography (PET) Nuclear Medicine Market

25.1. Spain Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market

26.1. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Positron Emission Tomography (PET) Nuclear Medicine Market

27.1. Russia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Positron Emission Tomography (PET) Nuclear Medicine Market

28.1. North America Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Positron Emission Tomography (PET) Nuclear Medicine Market

29.1. USA Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Positron Emission Tomography (PET) Nuclear Medicine Market

30.1. Canada Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Positron Emission Tomography (PET) Nuclear Medicine Market

31.1. South America Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market

32.1. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market

33.1. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Positron Emission Tomography (PET) Nuclear Medicine Market

34.1. Africa Positron Emission Tomography (PET) Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Segmentation By Procedure, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Positron Emission Tomography (PET) Nuclear Medicine Market Regulatory and Investment Landscape

36. Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Landscape And Company Profiles

36.1. Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Positron Emission Tomography (PET) Nuclear Medicine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Positron Emission Tomography (PET) Nuclear Medicine Market Company Profiles

36.3.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Canon Medical Systems Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Positron Emission Tomography (PET) Nuclear Medicine Market Other Major And Innovative Companies

Shimadzu Corporation, Toshiba America Medical Systems Inc., Mediso Medical Imaging Systems Ltd., Lantheus Holdings Inc., Jubilant DraxImage Inc., Advanced Accelerator Applications, Eckert & Ziegler Strahlen- und Medizintechnik AG, Cardinal Health, NorthStar Medical Radioisotopes LLC, Bruker Corporation, Digirad Corporation, Neusoft Medical Systems Co. Ltd., Agfa HealthCare NV, Bayer AG, Positron Corporation

38. Global Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Positron Emission Tomography (PET) Nuclear Medicine Market

40. Positron Emission Tomography (PET) Nuclear Medicine Market High Potential Countries, Segments and Strategies

40.1 Positron Emission Tomography (PET) Nuclear Medicine Market In 2030 - Countries Offering Most New Opportunities

40.2 Positron Emission Tomography (PET) Nuclear Medicine Market In 2030 - Segments Offering Most New Opportunities

40.3 Positron Emission Tomography (PET) Nuclear Medicine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Overview Of Key Products - Product Examples
  • Table 2: Global Positron Emission Tomography (PET) Nuclear Medicine Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Supply Chain Analysis
  • Table 4: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Major Raw Material Providers
  • Table 5: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Major Resource Providers
  • Table 6: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Major Manufacturers (Suppliers)
  • Table 7: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Major Distributors And Channel Partners
  • Table 8: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Key Technologies & Future Trends
  • Table 9: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Major Trends
  • Table 10: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Major End Users
  • Table 11: Global Positron Emission Tomography (PET) Nuclear Medicine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Positron Emission Tomography (PET) Nuclear Medicine Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Positron Emission Tomography (PET) Nuclear Medicine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Positron Emission Tomography (PET) Nuclear Medicine Market - TAM, US$ Billion, 2025
  • Table 15: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of F-18, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of Rb-82, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Positron Emission Tomography (PET) Nuclear Medicine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Positron Emission Tomography (PET) Nuclear Medicine Market - Company Scoring Matrix
  • Table 98: Siemens Healthineers AG Financial Performance
  • Table 99: GE HealthCare Technologies Inc. Financial Performance
  • Table 100: Koninklijke Philips N.V. Financial Performance
  • Table 101: Canon Medical Systems Corporation Financial Performance
  • Table 102: Fujifilm Holdings Corporation Financial Performance
  • Table 103: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Competitive Dashboard
  • Table 105: Global Positron Emission Tomography (PET) Nuclear Medicine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Positron Emission Tomography (PET) Nuclear Medicine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 107: Global, Positron Emission Tomography (PET) Nuclear Medicine Market Size Gain ($ Billion), Segmentation By Procedure, 2025 – 2030
  • Table 108: Global, Positron Emission Tomography (PET) Nuclear Medicine Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Positron Emission Tomography (PET) Nuclear Medicine Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Supply Chain Analysis
  • Figure 4: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Major Raw Material Providers
  • Figure 5: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Major Resource Providers
  • Figure 6: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Major Distributors And Channel Partners
  • Figure 8: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Key Technologies & Future Trends
  • Figure 9: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Major Trends
  • Figure 10: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Major End Users
  • Figure 11: Global Positron Emission Tomography (PET) Nuclear Medicine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Positron Emission Tomography (PET) Nuclear Medicine Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Positron Emission Tomography (PET) Nuclear Medicine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Positron Emission Tomography (PET) Nuclear Medicine Market - TAM, US$ Billion, 2025
  • Figure 15: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of F-18, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of Rb-82, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Positron Emission Tomography (PET) Nuclear Medicine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Positron Emission Tomography (PET) Nuclear Medicine Market - Company Scoring Matrix
  • Figure 98: Siemens Healthineers AG Financial Performance
  • Figure 99: GE HealthCare Technologies Inc. Financial Performance
  • Figure 100: Koninklijke Philips N.V. Financial Performance
  • Figure 101: Canon Medical Systems Corporation Financial Performance
  • Figure 102: Fujifilm Holdings Corporation Financial Performance
  • Figure 103: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Competitive Dashboard
  • Figure 105: Global Positron Emission Tomography (PET) Nuclear Medicine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Positron Emission Tomography (PET) Nuclear Medicine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 107: Global, Positron Emission Tomography (PET) Nuclear Medicine Market Size Gain ($ Billion), Segmentation By Procedure, 2025 – 2030
  • Figure 108: Global, Positron Emission Tomography (PET) Nuclear Medicine Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Smart Traffic Camera Market 2024 – By Component (Hardware, Software, Services), By Camera Type (Fixed Cameras, Mobile Speed Camera, Red Light Camera, Surveillance Camera, Traffic Monitoring Camera, Automatic Number Plate...

Software Services Market Report 2026 - Global Outlook – By Software (Finance, Sales And Marketing, Human Resource, Supply Chain), By Service (Consulting, Managed Services, Support And Maintenance), By Deployment (Cloud, ...

Nuclear Imaging Devices And Equipment Market Report 2026 - Global Outlook – By Product Type (SPECT Systems, PET Systems, Planar Scintigraphy Systems), By Application (Oncology, Cardiology, Neurology, Other Applications),...

Property And Casualty Insurance Market Report 2026 - Global Outlook – By Coverage (Fire And Theft, House Damage, Floods And Earthquake, Personal Property, Other Coverages), By Distribution Channel (Insurance Brokers, Ins...

Luxury Hotel Market Report 2026 - Global Outlook – By Type (Business Hotels, Airport Hotels, Suite Hotels, Resorts, Other Types), By Room Type (Luxury, Upper-Upscale, Upscale), By Category (Chain, Independent) – Market S...

Note Sorter Market Report 2026 - Global Outlook – By Sorter Type (Small-Sized Note Sorter, Medium-Sized Note Sorter, Large-Sized Note Sorter), By Enterprise Size (Large Enterprises, Small And Medium Enterprises ), By End...

Hemato Oncology Testing Market Report 2026 - Global Outlook – By Product And Services (Assay Kits And Reagents, Services), By Cancer Type (Leukemia, Lymphoma, Multiple Myeloma), By Technology (Polymerase Chain Reaction (...

3D Display Market Report 2026 - Global Outlook – By Product ( Volumetric, Stereoscopic), By Technology ( Digital Light Processing, Organic Light-Emitting Diode), By Access Methods ( Conventional or Screen-based Display, ...

Frequently Asked Questions

The Positron Emission Tomography (PET) Nuclear Medicine market was valued at $13.16 billion in 2025, increased to $15.06 billion in 2026, and is projected to reach $25.7 billion by 2030.

The global Positron Emission Tomography (PET) Nuclear Medicine market is expected to grow at a CAGR of 14.3% from 2026 to 2035 to reach $25.7 billion by 2035.

Some Key Players in the Positron Emission Tomography (PET) Nuclear Medicine market Include, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Shimadzu

Major trend in this market includes: Advancements In The PET Nuclear Medicine Market. For further insights on this market. request a sample here

North America was the largest region in the positron emission tomography (PET) nuclear medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission to

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us